An outlook on vascular hydrogen sulphide effects, signalling, and therapeutic potential

Archives of Physiology and Biochemistry

Volumn 119, Issue 5, 2013, Pages 189-194

  Popov, Doina ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Cystathionine lyase; Endoplasmic reticulum stress; Protein tyrosine phosphatase 1B (PTP1B); Sulfhydration

Indexed keywords

HYDROGEN SULFIDE;

BLOOD VESSEL; HUMAN; METABOLIC DISORDER; METABOLISM; METHODOLOGY; OXIDATIVE STRESS; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION; THERAPY;

BLOOD VESSELS; HUMANS; HYDROGEN SULFIDE; METABOLIC DISEASES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; THERAPEUTICS;

EID: 84887936870     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2013.803578     Document Type: Review

References (63)

1. Ahmad FU, Sattar MA, Rathore HA, et al. (2012). Exogenous hydrogen sulphide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail, 34, 203-10.
2. Bryan S, Yang G, Wang R, Khaper N. (2011). Cystathionine gammalyase-deficient smooth muscle cells exhibit redox imbalance and apoptosis under hypoxic stress conditions. Exp Clin Cardiol, 16, e36-41.
3. Coletta C, Papapetropoulos A, Erdelyi K, et al. (2012). Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci USA, 109, 9161-6.
4. Cuevasanta E, Denicola A, Alvarez B, Moller MN. (2012). Solubility and permeation of hydrogen sulfide in lipid membranes. PLoS ONE, 7, e34562.
5. Denizalti M, Bozkurt TE, Akpulat U, et al. (2011). The vasorelaxant effect of hydrogen sulfide is enhanced in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol, 383, 509-17.
6. Desai KM, Chang T, Untereiner A, Wu L. (2011). Hydrogen sulfide and the metabolic syndrome. Expert Rev Clin Pharmacol, 4, 63-73.
7. Elsey DJ, Fowkes RC, Baxter GF. (2010). Regulation of cardiovascular cell function by hydrogen sulfide H2S. Cell Biochem Funct, 28, 95-106.
8. Feng X, Chen Y, Zhao J, et al. (2009). Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun, 380, 153-9.
9. Finkel T. (2012). From sulfenylation to sulfhydration: what a thiolate needs to tolerate. Sci Signal, 5(215), pe10.
10. Fu M, Zhang W, Wu L, et al. (2012). Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc Natl Acad Sci USA, 109, 2943-48.
11. Gadalla MM, Snyder SH. (2010). Hydrogen sulfide as a gasotransmitter. J Neurochem, 113, 14-26.
12. Gao Y, Yao X, Zhang Y, et al. (2011). The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. Int J Cardiol, 152, 177-83.
13. Gough NR. (2012). First sulfhydration, then nitrosylation. Sci Signal, 5(208), ec26.
14. Gu X, Zhu YZ. (2011). Therapeutic applications of organosulfur compounds as novel hydrogen sulphide donors and/or mediators. Expert Rev Clin Pharmacol, 4, 123-33.
15. Jain SK, Bull R, Rains JL, et al. (2010). Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammationAntioxid Redox Signal, 12, 1333-7.
16. Kabil O, Banerjee R. (2010). Redox biochemistry of hydrogen sulfide. J Biol Chem, 285, 21903-7.
17. Kimura H. (2011). Hydrogen sulphide: Its production and functions. Exp Physiol, 96, 833-5.
18. Kimura H, Shibuya N, Kimura Y. (2012). Hydrogen sulfide is a signaling molecule and a cytoprotectant. Antioxid Redox Signal, 17, 45-57.
19. King AL, Lefer DJ. (2011). Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injury. Exp Physiol, 96, 840-6.
20. Kohn C, Schleifenbaum J, Szijarto IA, et al. (2012). Differential effects of cystathionine-g-lyase-dependent vasodilatory H2S in periadventitial vasoregulation of rat and mouse aortas. PLoS One, 7, e41951.
21. Krishnan N, Fu C, Pappin DJ, Tonks NK. (2011). H2S-induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response. Sci Signal, 4(203), ra86.
22. Lavu M, Bhushan S, Lefer DJ. (2011). Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clin Sci, 120, 219-29.
23. Lee HJ, Mariappan MM, Feliers D, et al. (2012). Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells. J Biol Chem, 287, 4451-61.
24. Lei YP, Liu CT, Sheen LY, et al. (2010). Diallyl disulfide and diallyl trisulfide protect endothelial nitric oxide synthase against damage by oxidized low-density lipoprotein. Mol Nutr Food Res, 54, S42-52.
25. Li L, Moore PK. (2007). Putative biological roles of hydrogen sulfide in health and disease: A breath of not so fresh airTrends in Pharmacol Sci, 29, 84-90.
26. Li L, Whiteman M, Guan YY, et al. (2008). Characterization of a novel, water-soluble hydrogen sulfide releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation, 117, 2351-60. (Pubitemid 351653553)
27. Li YF, Xiao CS, Hui RT. (2009). Calcium sulphide (CaS), a donor of hydrogen sulfide (H2S): A new antihypertensive drugMedical Hypotheses, 73, 445-7.
28. Liu Y-H, Lu M, Hu LF, et al. (2012). Hydrogen sulfide in the mammalian cardiovascular system. Antioxidants & Redox Signalling, 17, 141-85.
29. Lynn EG, Austin RC. (2011). Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential. Expert Rev Clin Pharmacol, 4, 97-108.
30. Mancardi D, Penna C, Merlino A, et al. (2009). Physiological and pharmacological features of the novel gasotransmitter: hydrogen sulfide. Biochim Biophys Acta, 1787, 864-72.
31. Manna P, Jain SK. (2011). Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cz/- (PKC z/-) in 3T3l1 adipocytes. J Biol Chem, 286, 39848-59.
32. Martelli A, Testai L, Breschi MC, et al. (2012). Hydrogen sulfide: novel opportunity for drug discovery. Med Res Rev, 32, 1093-130.
33. Mustafa AK, Sikka G, Gazi SK, et al. (2011). Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res, 109, 1259-68.
34. Mustafa AK, Gadalla MM, Sen, N, et al. (2009). H2S signals through protein S-Sulfhydration. Sci Signal, 2(96), ra72.
35. Olson KR. (2011). The therapeutic potential of hydrogen sulfide: separating hype from hope. Am J Physiol Regul Integr Comp Physiol, 301, R297-312.
36. Olson KR. (2012). A practical look at the chemistry and biology of hydrogen sulfide. Antioxid Redox Signal, 17, 32-44.
37. Paul BD, Snyder SH. (2012). H2S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol, 13, 499-507.
38. Peers C, Bauer C, Boyle JP, et al. (2012). Modulation of ion channels by hydrogen sulfide. Antioxid Redox Signal, 17, 95-105.
39. Pircher J, Fochler F, Czermak T, et al. (2012). Hydrogen sulfidereleasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo. Arterioscler Thromb Vasc Biol, 32, 2884-91.
40. Predmore BL, Lefer DJ, Gojon G. (2012). Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal, 17, 119-40.
41. Quiao W, Chaoshu T, Hongfang J, Junbao D. (2010). Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun, 396, 182-6.
42. Renga B. (2011). Hydrogen sulfide generation in mammals: The molecular biology of cystathionine-b-synthase (CBS) and cystathionine-g-lyase (CSE). Inflamm Allergy Drug Targets, 10, 85-91.
43. Sen U, Basu P, Abe OA, et al. (2009). Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol, 297, F410-9.
44. Shibuya N, Mikami Y, Kimura Y, et al. (2009). Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem, 146, 623-6.
45. Skovgaard N, Gouliaev A, Aalling M, Simonsen U. (2011). The role of endogenous H2S in cardiovascular physiology. Curr Pharm Biotechnol, 12, 1385-93.
46. Sparatore A., Santus G, Giustarini D, et al. (2011). Therapeutic potential of new hydrogen sulfide-releasing hybrids. Expert Rev Clin Pharmacol, 4, 109-21.
47. Streeter E, Hart J, Badoer E. (2012). An investigation of the mechanisms of hydrogen sulphide-induced vasorelaxation in rat middle cerebral arteries. Naunyn Schmiedebergs Arch Pharmacol, 385, 991-1002.
48. Szabo C. (2012). Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal, 17, 68-80.
49. Taniguchi S, Niki I. (2011). Significance of hydrogen sulfide production in the pancreatic b-cell. J Pharmacol Sci, 116, 1-5.
50. Vandiver M, Snyder SH. (2012). Hydrogen sulfide: A gasotransmitter of clinical relevance. J Mol Med (Berl), 90, 255-63.
51. Wagner CA. (2009). Hydrogen sulfide: A new gaseous signal molecule and blood pressure regulator. J Nephrol, 22, 173-6.
52. Wang R. (2012). Physiological implications of hydrogen sulfide: A whiff exploration that blossomed. Physiol Rev, 92, 791-896.
53. Wang R. (2002). Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitterFASEB J, 16, 1792-8. (Pubitemid 35340360)
54. Wang X, Wang Q, Guo W, Zhu YZ. (2011). Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: A mechanism through cardiac mitochondrial protection. Biosci Rep, 31, 87-98.
55. Wang Y, Zhao X, Jin H, et al. (2009). Role of hydrogen sulphide in the development of atherosclerotic lesions in Apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol, 29, 173-9.
56. Whiteman M, Gooding KM, Whatmore JL, et al. (2010). Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulfide. Diabetologia, 53, 1722-6.
57. Whiteman M, Trionnaire SL, Chopra M, et al. (2011). Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools. Clin Sci, 121, 459-88.
58. Yang G, Tang G, Zhang L, et al. (2011). The pathogenic role of cystathionine gamma-lyase/hydrogen sulfide in streptozotocininduced diabetes in mice. Am J Pathol, 179, 869-79.
59. Yang G, Wu L, Jiang B., et al. (2008). H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science, 322, 587-90.
60. Yang G, Pei Y, Cao Q, Wang R. (2012). MicroRNA-21 represses human cystathionine gamma-lyase expression by targeting at specificity protein-1 in smooth muscle cells. J Cell Physiol, 227, 3192-200.
61. Yuan P, Xue H, Zhou L, et al. (2011). Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol DialTransplant, 26, 2119-26.
62. Zavaczki E, Jeney V, Agarwal A, et al. (2011). Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int, 80, 731-9.
63. Zhao ZZ, Wang Z, Li G-H, et al. (2011). Hydrogen sulfide inhibits macrophage-derived foam cell formation. Exp Biol Med, 236, 169-76.